Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary?
- PMID: 31601721
- DOI: 10.1183/13993003.01494-2019
Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary?
Conflict of interest statement
Conflict of interest: R. Diel reports grants and personal fees from Bayer Vital, outside the submitted work. Conflict of interest: N.W. Schluger has nothing to disclose.
Comment on
-
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.Eur Respir J. 2019 Oct 10;54(4):1900982. doi: 10.1183/13993003.00982-2019. Print 2019 Oct. Eur Respir J. 2019. PMID: 31371444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources